US Patent Issued to SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES, ZHEJIANG HUAHAI PHARMACEUTICAL on Aug. 26 for "JAK kinase inhibitor, preparation method for same, and applications thereof in field of medicine" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,141, issued on Aug. 26, was assigned to SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES Co. LTD (Shanghai) and ZHEJIANG HUAHAI PHARMACEUTICAL Co. LTD. (Zhejiang, China).

"JAK kinase inhibitor, preparation method for same, and applications thereof in field of medicine" was invented by Xin Xu (Shanghai), Jia Chen (Shanghai), Zhen Zhang (Shanghai), Guan Wang (Shanghai), Linli Zhang (Shanghai), Qiang Li (Shanghai), Chenghao Xi (Shanghai), Minkai Qu (Shanghai), Xiaojuan Zhang (Shanghai), Chunqiao Chen (Shanghai), Fan Yang (Shanghai), Xiaoer Xia (Shanghai), Yijin Wang (Shanghai), Yunfei Li (Shanghai) and Jian Ge (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Of...